Biocatalytic cascade transformations for the synthesis of C-nucleosides and N-nucleoside analogs.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Pfeiffer M;Pfeiffer M; Nidetzky B; Nidetzky B; Nidetzky B
  • Source:
    Current opinion in biotechnology [Curr Opin Biotechnol] 2023 Feb; Vol. 79, pp. 102873. Date of Electronic Publication: 2023 Jan 09.
  • Publication Type:
    Journal Article; Review
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Elsevier Country of Publication: England NLM ID: 9100492 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0429 (Electronic) Linking ISSN: 09581669 NLM ISO Abbreviation: Curr Opin Biotechnol Subsets: MEDLINE
    • Publication Information:
      Publication: London : Elsevier
      Original Publication: London : Current Biology, c1990-
    • Subject Terms:
      Nucleosides*/metabolism ; Antineoplastic Agents*; Biocatalysis ; Nucleotides/metabolism ; Catalysis
    • Abstract:
      Nucleosides and their analogs, including those that feature substitution of the canonical N-glycosidic by a C-glycosidic linkage, provide access to potent antiviral, antibacterial, and antitumor drugs. Furthermore, they are key building blocks of m-RNA vaccines and play a crucial role for vaccine therapeutic effectiveness. As the medicinal applications of nucleosides increase in number and importance, there is a growing need for efficiency-enhanced routes of nucleoside synthesis. Cascade biocatalysis, that is, the application of natural or evolved enzymes promoting complex transformations in multiple steps in one pot and without the need of intermediate purification, emerges as a powerful tool to obtain nucleosides from readily available starting materials. Recent efforts in enzyme discovery and protein engineering expand the toolbox of catalysts active toward nucleosides or nucleotides. In this review, we highlight recent applications, and discuss challenges, of cascade biocatalysis for nucleoside synthesis. We focus on C-nucleosides and important analogs of the canonical N-nucleosides.
      Competing Interests: Conflict of interest statement Nothing declared.
      (Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)
    • Accession Number:
      0 (Nucleosides)
      0 (Nucleotides)
      0 (Antineoplastic Agents)
    • Publication Date:
      Date Created: 20230111 Date Completed: 20230207 Latest Revision: 20230212
    • Publication Date:
      20240829
    • Accession Number:
      10.1016/j.copbio.2022.102873
    • Accession Number:
      36630750